MAPK8 and thyroid gland carcinoma: These data suggest a mechanism by which sensitization of thyroid cancer cell lines to the combinatorial effects of TNFα-treatment and NF-κB inhibition requires activation of the JNK pathway that may, in fact, be cell line and tumor specific.